Heartbroken parents plead with Congress as children tragically die by suicide after disturbing interactions with AI chatbots, prompting OpenAI to develop a teen-friendly ChatGPT with age verification while experts demand stricter regulations and accountability for child safety online.
The SANDBOX Act proposes granting AI developers regulatory exemptions to foster innovation, sparking debate over balancing technological progress with public safeguards against privacy and security risks.
Donald Trump Jr.'s venture firm invests millions in Polymarket, a $1 billion predictions market that acquires CFTC-licensed QCEX, clearing regulatory hurdles for potential U.S. expansion.
Trump's AI czar David Sacks rallies tech leaders against 'AI doomerism', advocating for light regulation while urging the U.S. to out-innovate competitors and develop the biggest AI ecosystem.
Major tech companies are implementing safeguards as concerns arise over users seeking mental health advice from AI chatbots, while several states regulate or prohibit the use of AI systems for direct mental health services, posing challenges for investment firms betting on AI therapy chatbots.
Lina Khan, the former Federal Trade Commission chair, hails Figma's IPO as vindication of her scrutiny over tech giants' startup acquisitions, while critics argue Figma thrived despite regulatory hurdles.
Colorado and Illinois pass laws regulating AI in workplaces, prohibiting discrimination and mandating notice, as federal agencies apply existing laws and lawsuits mount over AI hiring tools, with over 30 states forming AI committees and California and New York expected to legislate in 2025.
California propels groundbreaking legislation, SB 243, mandating suicide prevention protocols, usage transparency, and third-party audits for AI companion chatbots, sparking debates over mental health risks and industry concerns about overreach.
The EU's Digital Markets Act aims to curb the dominance of tech giants like Google and Amazon by imposing strict rules, including data sharing and interoperability requirements, with hefty fines and potential breakups for non-compliance.
The FDA's new AI tool for reviewing medical devices, CDRH-GPT, is struggling with basic tasks like uploading documents and accessing recent studies, raising concerns about rushing AI adoption before it's ready to handle complex regulatory work accurately and safely.